Chester County News and Community Website
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) today unveiled a strategic move to safeguard its stockholders by adopting a limited duration stockholder rights agreement, commonly referred to as a …
Galera Therapeutics Implements Stockholder Rights Plan to Shield Investor Interests Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NASDAQ: WINT), a biotechnology firm, has declared a significant adjustment to its stock structure through a 1-for-18 reverse stock split. This strategic move, set …
Windtree Therapeutics Announces Reverse Stock Split in Strategy to Boost Market Compliance Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a biopharmaceutical company, has announced the issuance of inducement stock options to two newly hired employees. The Compensation Committee of Marinus’ Board …
Marinus Pharmaceuticals Awards Stock Options to New Employees as Inducement Read More
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has granted equity awards to 30 new hires under its 2023 Inducement Plan, as a key part of the employment package designed …
Madrigal Pharmaceuticals Awards Equity to New Employees as Inducement Read More
You’ve probably heard stories about fortunate investors who “get in the ground floor” of a new, hot company and quickly make a fortune. But while these things may happen, they …
Slow and Steady: A Smart Way to Invest Read More
RADNOR, PA — In a decisive move on March 12, 2024, NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) unveiled a comprehensive strategy aimed at curtailing short-selling activities that have beleaguered the company’s …
NRx Pharmaceuticals Takes Bold Steps Against Short Sellers, Plans to Rebrand as NRx Therapeutics Read More RADNOR, PA — NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, recently disclosed the sale of approximately 2.7 million shares of unregistered common stock along with an equal number of warrants …
NRx Pharmaceuticals Announces Sale of Unregistered Common Stock to Boost Clinical Trials Read More